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Dear Editor,
A 64 years-old man, with a history of myocardial infarction
and angioplasty with stent placement 3 months before, taking
aspirine and clopidogrel, was admitted due to melaenas since
the week before and syncope. The physical examination only
showed a pale man and there wasn’t any blood in the nasogas-
tric tube lavage. The blood samples presented haemoglobin of
6.8 g/dl.
The upper GI endoscopy revealed erosive gastropathy and
gastric ulcer (antrum) Forrest III, without any bleeding.
The patient was having a poor response to blood transfu-
sions, with a small haemoglobin increase from 6.8 to 8.4 g/dl
after 6 units of red blood cells.
Considering his cardiac risk he restarted the antiplatelet
therapy at the 8th day of hospitalization, having a new episode
of melaenas, dizziness, hypotension and drop of haemoglobin
(6.5 g/dl) 2 days later. The videocapsule enteroscopy showed
active bleeding in duodenum without discovering the primary
lesion. The pull-endoscopy revealed, in the Treitz’s angle, a
punctuate oozing lesion. Haemostatic treatment with adrenalin
(1:10,000-2.5 cc) was tried without success and a hemoclip was
placed to mark the spot. An exploratory laparotomy was per-
formed tracing the clip but not the causing lesion.
One month later, the patient had another clinical episode of
melaenas and haemoglobin of 6.4 g/dl. The upper endoscopy
revealed once again red blood since the Treitz’s angle and one
spot in a normal mucosa with active and pulsatile bleeding,
without associated ulcer. Haemostatic therapy with adrenalin
(1:10,000-6 cc), polidocanol 1% (4 cc) and argon plasma coag-
ulation was performed with success. After an 8 months follow-
up he remained asymptomatic.
Discussion
Dieulafoy’s lesion (DL) is a vascular malformation respon-
sible for 7% of upper gastrointestinal (GI) haemorrhage, mostly
massive, recurrent and without previous symptoms (1,2).
It is caused by a large-caliber, tortuous artery, without evi-
dence of vasculitis or atherosclerosis, that lies in the submu-
cosa with close contact with the mucosa, that ruptures into the
lumen, without causing mucosal ulceration or inflammation
(2-5).
Usually described in the stomach (75-95%), 6 cm below the
gastroesophageal junction near the lesser curvature, DL are
also described in duodenum (18%), colon (12%) small bowel
(2%) and oesophagus (2%) (2,6). In duodenum, as well in the
higher part of the lesser curvature, are not perfused by submu-
cosal plexus but instead derives their blood supply from the ter-
minal branches of average-caliber arteries, which could explain
the high DL incidence in these 2 areas (2,3,6).
Some studies consider the presence of significant comor-
bidities (cardiovascular diseases, diabetes or chronic renal fail-
ure) (2) as a possible precipitant factor, others consider the use
of alcohol or anti-inflammatory drugs (2,6). Our patient had
both.
The final diagnosis is made by endoscopy which is difficult
without active bleeding (3,5). Upper GI endoscopy has a low
sensibility (around 82%) (1,3) due to several causes: excessive
quantity of blood and clots in the stomach, small vessel, ves-
sel’s difficult localization among plies or coexisting other po-
tentially bleeding lesions (1,3,5). The endoscopic criteria pro-
posed to define DL are: a) active arterial spurting or
micropulsatile streaming; b) visualization of a protruding ves-
sel with or without active bleeding; and c) fresh recent clot with
a narrow attachment’s point, all three through normal surround-
ing mucosa or with minimal mucosal defect (6). A third of le-
sions were diagnosed at repeated endoscopy (3,6). It is becom-
ing more frequent that patients having double antiplatelet
therapy presented with GI bleeding with minimal mucosal de-
fects.
The treatment is endoscopic (1-3), with several options
(drugs injections, argon-plasma coagulation, electrocoagula-
tions or contact methods, hemoclip application or elastic band
ligation) (2,6). The use of thermocoagulation is advised in the
stomach but risky in duodenum due to its thin wall (6). In the
latter is advised the use of hemoclips or band ligation (6).
Surgery is rare, only in less than 5% of the cases (1,2,6). De-
spite its duodenal location we chose argon-plasma coagulation
because of being a recurrent hemorrhagic lesion.
DL is a rare but severe cause of upper GI bleeding that
should be aware in the endoscopist’s mind, especially for the
cases of recurrent and massive bleeding. Nowadays, endoscop-
ic techniques allow an effective treatment in most cases.
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